Clinical Trials Logo

Stage IIIB Intraocular Melanoma clinical trials

View clinical trials related to Stage IIIB Intraocular Melanoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02068586 Active, not recruiting - Iris Melanoma Clinical Trials

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Start date: November 19, 2014
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well sunitinib malate or valproic acid works in preventing high-risk uveal (eye) melanoma from spreading to other parts of the body. Sunitinib malate may stop the transmission of growth signals into tumor cells and prevents these cells from growing. Valproic acid may change the expression of some genes in uveal melanoma and suppress tumor growth.